Clinical Trials Logo

Clinical Trial Summary

Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world


Clinical Trial Description

Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world. The constitution of the atheroma plaque is linked to the deregulation of several biological phenomena, including angiogenesis, adipogenesis, inflammatory response, lipid metabolism and oxidative stress. In addition to its anatomical and physiological characteristics, the notion of plate stability is of paramount importance for clinical implications. This stability depends largely on the biological composition of the plate. A vulnerable or unstable plaque often has a large lipid body consisting of foam cells (macrophages laden with oxidized LDL) with a thin fibrous screed consisting of smooth muscle cells (CML), collagen fibers and extracellular matrix. This plaque is also made up of numerous inflammatory cells including macrophages, rich vascularization and intraplate hemorrhage. Although the cell composition of the unstable plate is still relatively established, its molecular analysis remains little known.

The benefit of carotid surgery in asymptomatic patients with stenosis greater than 70% is increasingly controversial given the moderate risk of spontaneous stroke under optimal medical treatment. This annual average risk is less than 5%. Thus, the discovery of an original and innovative biomarker, predictive of plate rupture, would define the patients most at risk, who benefit most from this surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03149406
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact Thierry REIX, PhD
Phone +33322455929
Email reix.thierry@chu-amiens.fr
Status Recruiting
Phase
Start date December 26, 2012
Completion date December 26, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05764772 - CT Evaluation of Carotid Plaque Components
Terminated NCT01132768 - The Confirmatory Olmesartan Plaque Regression Study Phase 4
Completed NCT03665818 - The Influence of Mandibular Advancement Device Treating OSAHS on Primary Prevention of Ischemic Stroke N/A
Enrolling by invitation NCT03308773 - Disease Prevention in Clinical Practice Base on Patient Specific Physiology
Active, not recruiting NCT05843487 - Association Between Carotid Plaque Length and Cardiovascular Outcomes
Completed NCT06187532 - Carotid Plaque-Burden Scale and Outcomes. A Real Life Study